trial · primary record
MK-1406
Influenza
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 10000 |
| Primary completion | 2027-06-30 |
| Primary endpoint | Number of Participants Experiencing Protocol-defined Influenza-like Illness (ILI) Occurring ≥7 Days after and up to 24 Weeks after Administration of Study Drug |
| Registry ID | NCT07159763 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:11.528Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07159763
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.